Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

PP-GWAS: Privacy Preserving Multi-Site Genome-wide Association Studies.

Nature communications·2025

Same author

Privacy-preserving AUC computation in distributed machine learning with PHT-meDIC.

PLOS digital health·2025

Same author

Target leakage and the use of diagnostic variables in diabetes prediction models.

Nutrition & diabetes·2025

Same author

Privacy-preserving federated unsupervised domain adaptation with application to age prediction from DNA methylation data.

Bioinformatics (Oxford, England)·2025

Same author

Long-term impact of the SARS-CoV-2 pandemic on respiratory viruses in Germany.

BMC public health·2025

Same author

Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled Trial.

JMIR research protocols·2025

Search research articles

Related Experiment Video

Updated: Feb 23, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Interpretable per case weighted ensemble method for cancer associations.

Adrin Jalali¹, Nico Pfeifer²

¹Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, Campus E1 4, Saarbrücken, 66123, Germany. ajalali@mpi-inf.mpg.de.

|July 21, 2016

Summary

This summary is machine-generated.

This study presents a novel method to accurately predict cancer type using molecular data, accounting for biases and enabling personalized patient predictions. The approach achieves state-of-the-art results and aids in discovering new therapeutic targets.

Keywords:

Cancer biomarkers Ensemble methods Gaussian processes Machine learning Supervised prediction Support vector machines

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Related Experiment Videos

Last Updated: Feb 23, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Area of Science:

Genomics
Bioinformatics
Cancer Research

Background:

Molecular measurements (gene expression, DNA methylation) in cancer patients are susceptible to external factors and patient heterogeneity, impacting prediction accuracy.
Existing models may fail when biases differ between training and testing datasets, leading to unreliable cancer staging predictions.

Purpose of the Study:

To develop a robust method for predicting cancer phenotypes from molecular data.
To address challenges posed by data biases and heterogeneity in cancer research.
To enable personalized phenotype prediction and facilitate exploratory data analysis.

Main Methods:

Introduced a novel method to estimate feature-level bias in molecular data.
Incorporated feature confidences into a weighted combination of classifiers.
Developed visualization tools for analyzing learned dependencies.

Main Results:

Achieved state-of-the-art performance on diverse cancer datasets (DNA methylation, gene expression).
Demonstrated personalized prediction adjusted for patient-specific biases.
Identified ribosomal proteins associated with leukemia risk groups, suggesting new research avenues.

Conclusions:

The new method offers robust phenotype prediction from molecular data, overcoming bias issues.
Visualization tools support exploratory analysis and personalized predictions.
The findings highlight ribosomes as a potential area for cancer gene regulation research.